Investigated
Can daily vitamin C reduce mortality or complications in people with precancerous blood disorders?Source
Daily 1,000 mg vitamin C may improve survival and cut serious complications in people with precancerous blood clones.
Oct 3, 2026
Source mix
3 of 12 institutional
Image: sciencenewstoday.org
The Story
The strongest interpretation is cautious. Randomization and placebo control make the trial informative, and the survival and complication findings justify further research. However, the primary endpoint was negative, the survival analysis was exploratory, and the sample was small. Current evidence therefore supports uncertainty and clinical-trial follow-up, not a recommendation that daily vitamin C reduces mortality.
- The randomized, double-blind design is a strength, but vitamin C failed to significantly slow abnormal clone growth, the study’s main objective.
- The apparent survival improvement was unexpected, exploratory, and not based on a trial designed to test mortality.
- A larger phase 3 trial is needed before concluding that vitamin C improves outcomes or should change clinical practice.
Deeper Insight
A more optimistic reading emphasizes that correcting commonly low vitamin C levels may improve resilience or inflammatory regulation without shrinking abnormal clones. The EVITA findings of fewer adverse events and an exploratory survival advantage are consistent with a supportive-care effect rather than direct anticancer activity. This interpretation remains provisional because the key survival result was exploratory and needs replication.
- Restoring vitamin C levels may influence inflammatory signaling and other biological processes even when abnormal clone growth is unchanged.
- The trial reported fewer adverse events and a favorable survival signal among participants receiving 1,000 mg/day.
- The findings could indicate a supportive-care benefit rather than elimination or slowing of the abnormal blood-cell clones.
Sources · 12
- 3 Journals & institutions
- 4 News reporting
- 5 Other / unclassified
What do these mean?
- Journals & institutions. Published in a peer-reviewed journal, or from a university, government body, court or other institution.
- News reporting. Journalism: newspapers, magazines and news sites.
- Other / unclassified. A site we have not classified yet. This says nothing good or bad about it.
Featured · Analysis · vai.org
Phase 2 trial suggests vitamin C may benefit people with pre-cancer blood disorders – Van Andel Institute
Other
# Phase 2 trial suggests vitamin C may benefit people with pre-cancer blood disorders – Van Andel Institute Published: 2026-09-21T07:02:29+00:00 Source: vai.org (vai.org) Language: en ## Story Phase 2 trial suggests vitamin C may benefit people with pre-cancer blood disorders – Van Andel Institute #
Read sourceAnalysis · sciencemediacentre.org
expert reaction to phase 2 trial looking at oral vitamin C supplementation in patients with pre-cancer blood disorders | Science Media Centre
Other
# expert reaction to phase 2 trial looking at oral vitamin C supplementation in patients with pre-cancer blood disorders | Science Media Centre Published: 2026-09-21T07:10:41+00:00 Source: sciencemediacentre.org (sciencemediacentre.org) Language: en ## Story expert reaction to phase 2 trial looking
Read sourceAnalysis · eurekalert.org
Can vitamin C improve outcomes in people with pre-cancer blood disorders? | EurekAlert!
News reporting
Can vitamin C improve outcomes in people with pre-cancer blood disorders? | EurekAlert! News Release 21-Sep-2026 # Can vitamin C improve outcomes in people with pre-cancer blood disorders? Phase 2 trial results warrant further study in a phase 3 trial Wiley Vitamin C boosts the activity of cellular
Read source